HbA<sub>1c</sub> Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regression.

MA, Bethel; R, Diaz; N, Castellana; I, Bhattacharya; HC, Gerstein; MC, Lakshmanan

doi:10.2337/dc20-1815

Public

HbA<sub>1c</sub> Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regression.

Shared by NobleBlocks on Jan 1, 2021 • 12:00 AM UTC

Authors:

Bethel MA

Diaz R

Castellana N

Abstract

<h4>Background</h4>Long-term glycemic control reduces retinopathy risk, but transient worsening can occur with glucose control intensification. Glucagon-like peptide 1 receptor agonists (GLP-1RA) lower glucose, but the long-term impact on retinopathy is unknown. GLP-1RA cardiovascular outcome trials...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!